Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing rinvatercept for ALS.
ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy - ...
Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS). This disease causes the immune system to mistakenly attack the protective ...
New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...
The human brain develops through an intricate balance of cellular growth, connectivity, and metabolism. A new study reveals ...
A newly identified role for the neuronal MPS shows it controls nutrient uptake by acting as a gatekeeper. Its disruption ...
Too much salt may inflame the brain, triggering hormones that push blood pressure higher. Scientists found this pathway could explain why many patients resist current hypertension drugs, pointing ...
ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson's disease and progressive supranuclear palsy - - ARV-102 was well tolerated across all dose levels following 28 ...
2don MSN
‘Pathway forward’ — Demolition approved for boarded-up Ambassador Bridge homes in west Windsor
More than a dozen west Windsor homes — long ago bought, emptied and left to rot by the owners of the Ambassador Bridge — are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results